TIDMSNG

RNS Number : 9105Z

Synairgen plc

28 January 2022

28 January 2022

Synairgen plc

("Synairgen" or the "Company")

Director/PDMR Dealing

Southampton, UK - 28 January 2022: Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs, announces that it was notified on 27 January 2022 that the spouse of Brooke Clarke, Senior Vice President, Head of Communications and PDMR, had purchased 8,520 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at an average price of 189.717p.

Following the purchase, the spouse of Brooke Clarke has a total interest over 8,520 Ordinary Shares, representing 0.004 per cent. of the Company's issued share capital.

For further information, please contact:

Synairgen plc

Richard Marsden, Chief Executive Officer

John Ward, Chief Financial Officer

Brooke Clarke, Head of Communications

Tel: +44 (0) 23 8051 2800

finnCap (NOMAD and Joint Broker)

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)

Alice Lane, Sunil de Silva (ECM)

Tel: +44 (0) 20 7220 0500

Numis Securities Limited (Joint Broker)

James Black, Freddie Barnfield, Duncan Monteith

Tel: +44 (0) 20 7260 1000

Consilium Strategic Communications (Financial Media and Investor

Relations)

Mary-Jane Elliott, Jessica Hodgson, Lucy Featherstone

synairgen@consilium-comms.com

Tel: +44 (0) 20 3709 5700

MK Strategies, LLC (US Media Relations)

Mary Conway

MConway@MKCStrategies.com

Tel: +1 516 606 6545

The notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

 
 1         Details of the person discharging managerial responsibilities/person 
            closely associated 
 (a)       Name                                         Thomas Clarke 
          -------------------------------------------  ----------------------------------------- 
 2         Reason for the notification 
          -------------------------------------------------------------------------------------- 
 a)        Position/status                              Person closely associated with Brooke 
                                                         Clarke, a PDMR 
          -------------------------------------------  ----------------------------------------- 
 b)        Initial notification/Amendment               Initial notification 
          -------------------------------------------  ----------------------------------------- 
 3         Details of issuer, emission allowance market participant, 
            auction platform, auctioneer or auction monitor 
          -------------------------------------------------------------------------------------- 
 a)        Name                                         Synairgen plc 
          -------------------------------------------  ----------------------------------------- 
 b)        LEI                                          213800IMMTOPPDF8HD24 
          -------------------------------------------  ----------------------------------------- 
 4         Details of the transaction(s): section to be repeated 
            for (i) each type of instrument; (ii) each type of transaction; 
            (iii) each date; and (iv) each place where transactions 
            have been conducted. 
          -------------------------------------------------------------------------------------- 
 a)        Description of                               Ordinary shares of 1p 
            the financial 
            instrument, type 
            of instrument 
            Identification                               ISIN: GB00B0381Z20 
            code 
          -------------------------------------------  ----------------------------------------- 
 b)        Nature of the                                Purchase of shares by spouse 
            transaction 
          -------------------------------------------  ----------------------------------------- 
 c)        Price(s) and volume(s)                       Price(s)               Volume(s) 
          -------------------------------------------  ---------------------  ------------------ 
                                                        GBP1.8974              7,899 
    GBP1.8942                                                                   621 
  --------------------------------------------------------------------------  ------------------ 
 
 d)             Aggregated information 
                  *    Aggregated volume                  8,520 Ordinary Shares 
                                                          GBP16,163.86p 
 
                  *    Price 
          -------------------------------------------  ----------------------------------------- 
 e)        Date of the transaction                      27 January 2022 
          -------------------------------------------  ----------------------------------------- 
 f)        Place of the transaction                     XLON 
          -------------------------------------------  ----------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEAPFXADLAEFA

(END) Dow Jones Newswires

January 28, 2022 02:00 ET (07:00 GMT)

Synairgen (LSE:SNG)
Gráfica de Acción Histórica
De Nov 2022 a Dic 2022 Haga Click aquí para más Gráficas Synairgen.
Synairgen (LSE:SNG)
Gráfica de Acción Histórica
De Dic 2021 a Dic 2022 Haga Click aquí para más Gráficas Synairgen.